Weekend ethanol consumption and high-sucrose diet: Resveratrol effects on energy expenditure, substrate oxidation, lipid profile, oxidative stress and hepatic energy metabolism

Alcohol and Alcoholism

Volumn 46, Issue 1, 2011, Pages 10-16

  Rocha, Katiucha Karolina Honório Ribeiro ^a   Souza, Gisele Aparecida ^a   Seiva, Fábio Rodrigues Ferreira ^a   Ebaid, Geovana Xavier ^a   Novelli, Ethel Lourenzi Barbosa ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ALANINE AMINOTRANSFERASE; ALCOHOL; CATALASE; CHOLESTEROL; CITRATE SYNTHASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; PROTEIN; RESVERATROL; SUCROSE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIMETRY; CARBOHYDRATE DIET; CONTROLLED STUDY; DYSLIPIDEMIA; ENERGY EXPENDITURE; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER METABOLISM; MALE; METABOLIC RATE; NONHUMAN; NUTRITIONAL PARAMETERS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ALCOHOL DRINKING; ANIMALS; ANTIOXIDANTS; DIETARY SUCROSE; ENERGY METABOLISM; ETHANOL; LIPID PEROXIDES; LIPIDS; LIVER; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; STILBENES; TIME FACTORS;

RATTUS;

EID: 78650360087     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agq085     Document Type: Article

References (49)

1. Aebi H. (1974) Methods of Enzymatic Analysis, 2nd edn. New York: Verlag Chemie Weinheim.
2. Ahan J, Cho I, Kim S et al. (2008) Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepathol 49:1019-28.
3. Bandele OJ, Clawson SJ, Osheroff N. (2008) Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chem Res Toxicol 21:1-8.
4. Bass A, Brdicka PE, Eyer P et al. (1969) Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem 10:198-206.
5. Baur JA, Sinclair DA. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506.
6. Baur JA, Pearson KJ, Price NL et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-42.
7. Brizzi P, Tonolo G, Carusillo F et al. (2003) Plasma lipid composition and LDL oxidation. Clin Chem Lab Med 4:56-60.
8. Burkitt MJ, Duncan J. (2000) Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. Arch Biochem Biophys 381:253-63.
9. Cho IJ, Ahan JY, Kim S et al. (2008) Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochem Biophysical Res Commun 367:190-94.
10. Crouse J, Grundy SM. (1984) Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J Lip Res 25:486-96.
11. Crowell JA, Korytko PJ, Morrissey RL et al. (2004) Resveratrol-associated renal toxicity. Toxicol Sci 82:614-19.
12. Dong Z. (2003) Molecular mechanism of the chemopreventive effect of resveratrol. Mutation Res 523:145-50.
13. Ewing JF, Janero DR. (1995) Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal Biochem 232:243-48.
14. Ferreira MP, Willoughby D. (2008) Alcohol consumption: the good, the bad, and the indifferent. Appl Physiol Nutr Metab 33:12-20.
15. Friedewald WT, Levy R, Fredrickson DS. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without preparative ultracentrifuge. Clin Chem 18:499-502.
16. Hou X, Xu S, Maitland KA et al. (2009) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283:20015-26.
17. 3+ in the presence of xylenol orange. Lipids 26:853-56.
18. Juan ME, Buenafuente J, Casals I et al. (2002) Plasmatic levels of trans-resveratrol in rats. Food Res Int 35:195-9.
19. Labayen I, Forga L, Martinez JA. (1999) Nutrient oxidation and metabolic rate as affected by meals containing different proportions of carbohydrate and fat, in healthy young women. Eur J Nutr 38:158-66.
20. Lowry DH, Rosebrough NJ, Farr AL. (1951) Protein measurement with the folin-phenol reagent. J Biol Chem 193:265-75.
21. Mattes R. (2006) Fluid calories and energy balance: the good, the bad, and the uncertain. Physiol Behav 89:66-70.
22. Milde J, Elstner EF, Grabmann J. (2007) Synergistic effects of polyphenols and carotenoids on human low-density lipoprotein oxidation. Mol Nutr Food Res 51:956-61.
23. Murray RP, Connet JE, Tyn SY et al. (2002) Alcohol volume, drinking pattern and cardiovascular disease morbidity and mortality: is there a J-shaped function? Am J Epidemiol 155:212-18.
24. Nakamura W, Hosoda S, Hayashi K. (1974) Purification and properties of rat liver glutathione preoxidase. Biochim Biophys Acta 358:251-61.
25. Novelli ELB. (2005) Nutrição e vida saudável. Estresse Oxidativo e metabolismo energético. São Paulo: Tecmedd Editora.
26. Novelli ELB, Rodrigues NL, Ribas BO et al. (1996) Toxicity of chronic ethanol ingestion and superoxide radical formation on seminal vesicles of rats. Food Chem Toxicol 34:1003-7.
27. Novelli ELB, Rodigues NL, Santos CXC et al. (1997) Toxic effects of alcohol intake on prostate of rats. Prostate 31:37-42.
28. Novelli ELB, Diniz YS, Galhardi CM et al. (2007) Anthropometrical parameters and markers of obesity in rats. Lab Anim 41:111-19.
29. Novelli ELB, Santos P, Assalin H et al. (2009) N-acetylcysteine in high sucrose induced obesity: energy expenditure, metabolic shifting for cardiac health. Pharmacol Res 59:74-9.
30. Novelli ELB, Souza GA, Ebaid GMX et al. (2010) Energy expenditure and oxygen consumption as novel biomarkers of obesity-induced cardiac disease in rats. Obesity 18:1754-61.
31. Oak MH, Bedour JE, Schini-Kerth VB. (2005) Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16:1-8.
32. Ojeda ML, Delgado-Villa J, Llopis R et al. (2008) Lipid metabolism in ethanol-treated rat pups and adults: effects of folic acid. Alcohol Alcohol 43:544-50.
33. Park CE, Kim MJ, Lee JH et al. (2007) Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp Mol Med 39:222-9.
34. Pinheiro-Mulder A, Aquila MB, Bregman R et al. (2010) Exercise counters diet-induced obesity, proteinuria and structural kidney alterations in rat. Pathol Res Pract 15:168-73.
35. Poudyal H, Panchal S, Brown L. (2010) Comparison of purple carrot juice and beta-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr 12:1-11.
36. Puddey IB, Rakic V, Dimmitt SB et al. (1999) Influence of pattern of drinking on cardiovascular risk factors-a review. Addiction 94:649-63.
37. Rivera L, Morón R, Zarzuelo A et al. (2009) Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77:1053-63.
38. Rocha KKHR, Souza GA, Ebaid GMX et al. (2009) Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem Toxicol 47:1362-7.
39. Seiva FRF, Amauchi JF, Rocha KK et al. (2009a) Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats. Alcohol 43:127-35.
40. Seiva FRF, Amauchi JF, Rocha KKHR et al. (2009b) Alcoholism and alcohol abstinence: N-acetylcysteine to improve energy expenditure, myocardial oxidative stress, and energy metabolism in alcoholic heart disease. Alcohol 43:649-56.
41. Seiva FRF, Berbert CMS, Souza GA et al. (2010) Energy expenditure, lipid profile, oxidative stress and cardiac energy metabolism after growth hormone treatment in obese young rats. Horm Metab Res 42:496-501.
42. Seve M, Chimienti F, Devergnas S et al. (2005) Resveratrol enhances UVA-induced DNA damage in HaCat human keratinocytes. Med Chem 1:629-33.
43. Suter PM, Tremblay A. (2005) Is alcohol consumption a risk factor for weight gain and obesity?. Crit Rev Clin Lab Sci 42:197-227.
44. Szkudelski T. (2006) Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur J Pharmacol 552:176-81.
45. Tolstrup J, Jensen MK, Tjonneland A et al. (2006) Prospective study of alcohol drinking patterns and coronary heart disease in women and men. BMJ 332:1244-48.
46. Trevisan M, Dom J, Falkner R et al. (2001) Drinking pattern and risk of non-fatal myocardial infarction: a population base-control study. Addiction 99:313-22.
47. Turner RT, Evans G, Zhang M et al. (1999) Is resveratrol an estrogen agonist in growing rats? Endocrinology 140:50-4.
48. Wang Z, Zou J, Cao K et al. (2005) Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 16:533-40.
49. Wilson-Fritch L, Nicoloro S, Choulnard M et al. (2004) Mitochondrial remodelling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114:1281-89.